Global Humira Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 117

Report ID: 5307

Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion in 2017 is about 43%, and the proportion is in decreasing trend from 2013 to 2017.
USA is the largest market, with a sales market share nearly 65% in 2017. Following USA, Europe is the second largest market with the sales market share of 30%.
The global Humira market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Humira market based on company, product type, end user and key regions.

This report studies the global market size of Humira in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Humira in these regions.
This research report categorizes the global Humira market by top players/brands, region, type and end user. This report also studies the global Humira market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Cadila Healthcare
Torrent Pharmaceuticals
Boehringer Ingelheim

Market size by Product
Humira Syringe
Humira Pen
Market size by End User
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:
To study and analyze the global Humira market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Humira market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Humira companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Humira submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Humira are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Humira market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Humira Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Humira Market Size Growth Rate by Product
1.4.2 Humira Syringe
1.4.3 Humira Pen
1.5 Market by End User
1.5.1 Global Humira Market Size Growth Rate by End User
1.5.2 Ankylosing Spondylitis
1.5.3 Rheumatoid Arthritis
1.5.4 Crohn’s Disease
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Humira Market Size
2.1.1 Global Humira Revenue 2014-2025
2.1.2 Global Humira Sales 2014-2025
2.2 Humira Growth Rate by Regions
2.2.1 Global Humira Sales by Regions
2.2.2 Global Humira Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Humira Sales by Manufacturers
3.1.1 Humira Sales by Manufacturers
3.1.2 Humira Sales Market Share by Manufacturers
3.1.3 Global Humira Market Concentration Ratio (CR5 and HHI)
3.2 Humira Revenue by Manufacturers
3.2.1 Humira Revenue by Manufacturers (2014-2019)
3.2.2 Humira Revenue Share by Manufacturers (2014-2019)
3.3 Humira Price by Manufacturers
3.4 Humira Manufacturing Base Distribution, Product Types
3.4.1 Humira Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Humira Product Type
3.4.3 Date of International Manufacturers Enter into Humira Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Humira Sales by Product
4.2 Global Humira Revenue by Product
4.3 Humira Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Humira Breakdown Data by End User

6 North America
6.1 North America Humira by Countries
6.1.1 North America Humira Sales by Countries
6.1.2 North America Humira Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Humira by Product
6.3 North America Humira by End User

7 Europe
7.1 Europe Humira by Countries
7.1.1 Europe Humira Sales by Countries
7.1.2 Europe Humira Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Humira by Product
7.3 Europe Humira by End User

8 Asia Pacific
8.1 Asia Pacific Humira by Countries
8.1.1 Asia Pacific Humira Sales by Countries
8.1.2 Asia Pacific Humira Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Humira by Product
8.3 Asia Pacific Humira by End User

9 Central & South America
9.1 Central & South America Humira by Countries
9.1.1 Central & South America Humira Sales by Countries
9.1.2 Central & South America Humira Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Humira by Product
9.3 Central & South America Humira by End User

10 Middle East and Africa
10.1 Middle East and Africa Humira by Countries
10.1.1 Middle East and Africa Humira Sales by Countries
10.1.2 Middle East and Africa Humira Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Humira by Product
10.3 Middle East and Africa Humira by End User

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Humira Products Offered
11.1.5 AbbVie Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Company Business Overview
11.2.3 Eisai Humira Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Eisai Humira Products Offered
11.2.5 Eisai Recent Development
11.3 Cadila Healthcare
11.3.1 Cadila Healthcare Company Details
11.3.2 Company Business Overview
11.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Cadila Healthcare Humira Products Offered
11.3.5 Cadila Healthcare Recent Development
11.4 Torrent Pharmaceuticals
11.4.1 Torrent Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Torrent Pharmaceuticals Humira Products Offered
11.4.5 Torrent Pharmaceuticals Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Company Business Overview
11.5.3 Amgen Humira Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Amgen Humira Products Offered
11.5.5 Amgen Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Company Business Overview
11.6.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Boehringer Ingelheim Humira Products Offered
11.6.5 Boehringer Ingelheim Recent Development

12 Future Forecast
12.1 Humira Market Forecast by Regions
12.1.1 Global Humira Sales Forecast by Regions 2019-2025
12.1.2 Global Humira Revenue Forecast by Regions 2019-2025
12.2 Humira Market Forecast by Product
12.2.1 Global Humira Sales Forecast by Product 2019-2025
12.2.2 Global Humira Revenue Forecast by Product 2019-2025
12.3 Humira Market Forecast by End User
12.4 North America Humira Forecast
12.5 Europe Humira Forecast
12.6 Asia Pacific Humira Forecast
12.7 Central & South America Humira Forecast
12.8 Middle East and Africa Humira Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Humira Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer